Thromb Haemost 2009; 101(06): 997-998
DOI: 10.1160/TH09-05-0294
Theme Issue Editorial
Schattauer GmbH

Recent advances in vascular biology: Selected highlights from IVBM 2008

Levon M. Khachigian
1   Centre for Vascular Research, University of New South Wales, Sydney NSW, Australia
,
Karlheinz Peter
2   Baker IDI Heart and Diabetes Institute, Melbourne VIC, Australia
,
Michael C. Berndt
3   College of Medicine and Health, University College, Cork, Ireland.
› Author Affiliations
Further Information

Publication History

Received: 08 May 2009

Accepted: 08 May 2009

Publication Date:
24 November 2017 (online)

 

 
  • References

  • 1 Griffioen AW, Damen CA, Blijham GH. et al. Tumor angiogenesis is accompanied by a decreased inflammatory response of tumor-associated endothelium. Blood 1996; 15 (88) 667-673.
  • 2 Griffioen AW, Vyth-Dreese FA. Angiostasis as a way to improve immunotherapy. Thromb Haemost 2009; 101: 1025-1031.
  • 3 Kidoya H, Ueno M, Yamada Y. et al. Spatial and temporal role of the apelin/APJ system in the caliber size regulation of blood vessels during angiogenesis. Embo J 2008; 27: 522-534.
  • 4 Takakura N, Kidoya H. Maturation of blood vessels by haematopoietic stem cells and progenitor cells: involvement of apelin/APJ and angiopoietin/Tie2 interactions in vessel caliber size regulation. Thromb Haemost 2009; 101: 999-1005.
  • 5 Hynes RO. Integrins: bidirectional, allosteric signaling machines. Cell 2002; 110: 673-687.
  • 6 Petrich B. Talin. Dependent integrin signaling in vivo. Thromb Haemost 2009; 101: 1020-1024.
  • 7 Toleikis L, Broders O, Dubel S. Cloning single-chain antibody fragments (scFv) from hybridoma cells. Methods Mol Med 2004; 94: 447-458.
  • 8 Hagemeyer CE, von zur Muhlen C, von Elverfeldt D. et al. Single-chain antibodies as diagnostic tools and therapeutic agents. Thromb Haemost 2009; 101: 1012-1019.
  • 9 Newby AC. Matrix metalloproteinases regulate migration, proliferation, and death of vascular smooth muscle cells by degrading matrix and non-matrix substrates. Cardiovasc Res 2006; 69: 614-624.
  • 10 Newby AC, George SJ, Ismail Y. et al. Vulnerable atherosclerotic plaque metalloproteinases and foam cell phenotypes. Thromb Haemost 2009; 101: 1006-1011.
  • 11 Verhoeven BA, Velema E, Schoneveld AH. et al. Athero-express: differential atherosclerotic plaque expression of mRNA and protein in relation to cardiovascular events and patient characteristics. Rationale and design. European journal of epidemiology 2004; 19: 1127-1133.
  • 12 Hurks R, Peeters W, Derksen WJ. et al. Biobanks and the search for predictive biomarkers of local and systemic outcome in atherosclerotic disease. Thromb Haemost 2009; 101: 48-54.